Praemissae sunt Henrici Stephani ad Io. Cratonem A. Craftheim epistolae ex autographis nunc primum editae ... /

Includes index.

Consiliorum, et epistolarum medicinalium, Ioh. Cratonis a Kraftheim ... et aliorum praestantissimorum medicorum, liber quartus /

Mode of access: Internet.

Hans von Bülow, Johannes Brahms, Doppelbildnis, Brustbild

Signatur des Originals: S 36/F08255

Die Adamsbrücke und die kórallenriffe der Palkstrasse. Sedimentstudien im tropischen litoralgebiet von Dr. Johannes Walther ... Mit einer karte.

Bound with: Wagner, H. and Supan, A. Areal und bevölkerung.

Heinrich von Navarra und Deutschland (1585-1586) : Kap. II.

Thesis (doctoral)--Friedrich-Wilhelms-Universitat zu Berlin.

Lebensbeschreibungen der drey auszeichnetsten Vorläufer des berühmten M. Johannes Hus von Hussinecz, benanntlich: des Konrad Stiekna, Johannes Milcz, und Mathias von Janor; nebst einer kurzen Uebersicht der böhmischen Religionsgeschichte bis auf seine Zeit.

Mode of access: Internet.

Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion

Sir, anti TNF-α agents (aTNFs) are the most commonly prescribed biological agents in RA. More recently abatacept (ABA), a T-cell costimulation modulator, and rituximab (RTX), a monoclonal antibody directed against CD20, have become available. Observational studies suggest that switching to a new drug class may be more effective in uncontrolled RA than switching to a class of biologics to which the patient had unsuccessfully been exposed [1]. Information about the efficacy and safety of cycling strategies through third-line biologics is lacking. This study aimed to analyse the effectiveness and safety of switching patients to ABA as the third biological class after failure of aTNF plus RTX. The Swiss Clinical Quality Management (SCQM) programme for RA is a longitudinal population-based cohort, which has been approved by the local ethics committees of all participating centres [2]. For this analysis, we collected all the …

Use of abatacept in rheumatoid arthritis

Abatacept (CTLA-Ig), a modulator of T-lymphocyte activation, has been approved by the Swiss health regulatory agency Swissmedic for the treatment of active rheumatoid arthritis (RA). This article summarises the key trial findings for this biologic agent in RA in different situations such as early erosive rheumatoid arthritis (RA), biologic-naïve RA, RA before and after the use of methotrexate or TNF-inhibitors and includes safety information from these trials. Based on these data, recommendations for clinical practice in Switzerland are made by a panel of experts.

A common origin of the 4143insA ADAMTS13 mutation

Severely deficient activity of the von Willebrand Factor (VWF) cleaving metalloprotease, ADAMTS13, is associated with thrombotic thrombocytopenic purpura (TTP). The mutation spectrum ofADAMTS13 is rather heterogeneous, and numerous mutations spread across the gene have been described in association with congenital TTP. The 4143insA mutation is unusual with respect to its geographic concentration. Following the initial report from Germany in which the 4143insA mutation was detected in four apparently unrelated families, we have now identified this mutation in a further eleven patients from Norway, Sweden, Poland, Germany, the Czech Republic and Australia. Confirmation that the Australian patient is of German ancestry, together with the Northern and Central European origin of most of the other patients, suggests that the 4143insA mutation has a common genetic background. We established ADAMTS13 haplotypes by analyzing 17 polymorphic intragenic markers. The haplotypes linked to 4143insA were identical in all informative families. Three novel candidate mutations, C347S, P671L and R1060W, as well as the known mutation R507Q, were also identified during the course of the study. We conclude that 4143insA has a common genetic background and is frequent among patients with hereditary ADAMTS13 deficiency in Northern and Central European countries.

Die Fieber und deren Behandlung nach homöopathischen Grundsätzen

bearbeitet von Dr. Johannes Göbel, praktischem Arzte in Danzig

Die acuten Krankheiten und deren Behandlung nach homöopathischen Grundsätzen

bearbeitet von Dr. Johannes Göbel, praktischem Arzte in Danzig

Questiones Joânis Sandoni de celo [et] mûdo [Texto impreso]

Marca de imp. en la última h.

De historia SS. imaginum et picturarum, pro vero earum usu contra abusus, libri quatuor /

Addenda, p. 569-76. Errata, p. 675-6.

Kitâb al-Fihrist,

"Zweiter Band, die Anmerkungen und Indices enthaltend, von Dr. August Mueller."